Dr. Mezouar gained her Ph.D. degree from Aix-Marseille University, France in 2015 where she also finished her postdoctoral position on the topic of immune mechanisms involved in infectious inflammatory pathologies. She started her research with the investigation of the role of platelets and neutrophils in the thrombosis associated with cancer and in the concept of immunothrombosis. She joined a research unit involved in the study of the role of macrophages during the sterile inflammatory process and during intracellular pathogens infection. Her research project was oriented on investigating the function and polarization of placenta macrophages to infection. Actually, she focused her research on macrophages and their interactions with other immune cells during immunothrombosis processes. From 2020 to 2022 she was head of the in vivo and in vitro biology-pharmacology team at Genoscience Pharma for the project of the development of autophagy inhibitor drugs in infectious, autoimmune diseases and cancer. She is a member of the European Academy of Allergy & Clinical Immunology and the French Society of Immunology. She has done peer reviews for journals such as Blood Advances, Cell Communication and Signaling, Journal of Immunology, Frontiers in Microbiology, Frontiers in Immunology, Frontiers in Oncology, Microbial Pathogenesis, Viruses, Pathogens, etc.